|
ZBTB11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.742400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.289400E-01 |
| Normal-vs-Stage2 |
9.343400E-01 |
| Normal-vs-Stage3 |
1.378200E-01 |
| Normal-vs-Stage4 |
1.605800E-01 |
| Stage1-vs-Stage2 |
9.734200E-01 |
| Stage1-vs-Stage3 |
1.384570E-01 |
| Stage1-vs-Stage4 |
1.804990E-01 |
| Stage2-vs-Stage3 |
3.422400E-01 |
| Stage2-vs-Stage4 |
3.498200E-01 |
| Stage3-vs-Stage4 |
9.808600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.414200E-01 |
| Normal-vs-AfricanAmerican |
5.810200E-02 |
| Normal-vs-Asian |
2.561000E-01 |
| Caucasian-vs-AfricanAmerican |
1.836390E-01 |
| Caucasian-vs-Asian |
1.175850E-01 |
| AfricanAmerican-vs-Asian |
2.559500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.588400E-02 |
| Normal-vs-Female |
3.508800E-01 |
| Male-vs-Female |
4.656800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.509400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.287200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.377780E-01 |
| Normal-vs-Age(81-100Yrs) |
3.879700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.769800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.220000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.580400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.921600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.595700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.016800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.661580E-01 |
| Normal-vs-Grade 2 |
4.731200E-01 |
| Normal-vs-Grade 3 |
4.860300E-02 |
| Normal-vs-Grade 4 |
2.360300E-02 |
| Grade 1-vs-Grade 2 |
2.448200E-01 |
| Grade 1-vs-Grade 3 |
8.201400E-03 |
| Grade 1-vs-Grade 4 |
1.420360E-02 |
| Grade 2-vs-Grade 3 |
6.779200E-03 |
| Grade 2-vs-Grade 4 |
8.218600E-03 |
| Grade 3-vs-Grade 4 |
3.099600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.817800E-02 |
| Normal-vs-ccB subtype |
5.738200E-02 |
| ccA subtype-vs-ccB subtype |
2.641500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.795200E-01 |
| Normal-vs-N1 |
7.496400E-01 |
| N0-vs-N1 |
7.718200E-01 |
|
|
